This symposium will investigate the links between metabolic dysfunction and asthma, highlighting recent developments in clinical, translational and basic research. Topic 1 will review the mechanisms and management of obesity-related asthma. In Topic 2 the speaker will focus on the interplay of type 2 diabetes and asthma. In Topic 3 the speaker will present a novel pathway through the glucagon-like peptide-1 receptor as therapeutic target for asthma with and without metabolic dysfunction.
Upon completion of this activity, participants should be able to:
- Analyze mechanisms underlying associations between metabolic abnormalities and asthma
- Identify the need for new therapeutic approaches for individuals with asthma and metabolic dysfunction